ArticleNeurochemical research2025
Altered Inhibitory Synaptic Transmission and Changes in GABAergic Markers in the Hippocampus of Genetic and Environmental Animal Model of Autism.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Shank3B deficiency disrupts GABAergic synaptic transmission in pyramidal neurons of the medial prefrontal cortex region in autism spectrum disorder.Molecular brain · 2026Article
- GABAFrontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Changes in hippocampal neurons are known to play a critical role in social memory deficits associated with autism spectrum disorders (ASD). Although the theory of excitatory-inhibitory imbalance in autism pathogenesis is well established, early developmental alterations in the hippocampus remain insufficiently characterized. Alterations in gamma-aminobutyric acid (GABA)ergic neurons and their markers are thought to underlie synaptic changes in inhibitory circuits. Therefore, this study was designed to: (1) quantify glutamatergic and GABAergic neuron populations in the hippocampus; (2) characterize inhibitory postsynaptic currents (IPSCs) in primary hippocampal neurons; and (3) assess gene expression of selected GABAergic markers in two autism-like animal models, namely Shank3-deficient mice and prenatally valproate (VPA)-exposed rats. A reduced proportion of GABAergic neurons was observed in the hippocampus of both models. An increase in the number of glutamatergic neurons was found only in the hippocampus of prenatally VPA-exposed rats. This was accompanied by a decrease in IPSC frequency in primary hippocampal neurons from prenatally VPA-exposed rats, while no significant changes were found in Shank3-deficient mice. Altered temporal dynamics of inhibitory synaptic transmission were demonstrated in both models by a decreased cumulative probability of inter-event intervals for inhibitory currents. Furthermore, reduced gene expression levels of Gabarap and Gabarapl1 were detected in Shank3-deficient mice, whereas decreased Gat1 expression level was found in prenatally VPA-exposed rats at postnatal day 5. These findings strongly support the excitatory-inhibitory imbalance hypothesis in ASD. Thus, genetic or environmentally induced GABAergic changes in the hippocampus may underlie hippocampus-dependent social memory alterations in ASD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.